Clicky

BIOINVENT INTERN. SK 2(BIX0) News

Date Title
Jul 28 Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025
May 28 High Growth Tech Stocks In Europe May 2025
May 27 XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
Feb 27 BioInvent International AB: Year-End Report January 1 - December 31, 2024
Feb 25 Invitation to Presentation of BioInvent's Year-end Report 2024